198 assets in Major Depressive Disorder

Therapeutic assets addressing Major Depressive Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Xiongdan Wan Major Depressive Disorder	Shanghai Mental Health Center	P2	CCC (51)
Aticaprant Major Depressive Disorder	Janssen Research & Development, LLC	P3	CCC (50)
(2R,6R)-HYDROXYNORKETAMINE Major Depressive Disorder	National Institute of Mental Health (NIMH)	P2	CCC (49)
Anc-501 Major Depressive Disorder	Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.	P2	CCC (49)
E. Coli Endotoxin Major Depressive Disorder	Laureate Institute for Brain Research, Inc.	P1/2	CCC (49)
Baricitinib Major Depressive Disorder	Emory University	P2	CCC (48)
Elunetirom Major Depressive Disorder	Autobahn Therapeutics, Inc.	P2	CCC (48)
Empagliflozin Major Depressive Disorder	NYU Langone Health	P2	CCC (48)
Enoxolone Major Depressive Disorder	Philipps University Marburg	P1/2	CCC (48)
gm-2505 Major Depressive Disorder	Gilgamesh Pharmaceuticals	P2	CCC (48)
Icalcaprant Major Depressive Disorder	AbbVie	P2	CCC (48)
Palmitic Monoethanolamide Major Depressive Disorder	The Israeli Medical Center for Alzheimer's	P2	CCC (48)
Sodium Lactate Major Depressive Disorder	Centre Hospitalier Universitaire Vaudois	P2	CCC (48)
Tocilizumab Major Depressive Disorder	Massachusetts General Hospital	P2	CCC (48)
Ala-3000 Major Depressive Disorder	Alar Pharmaceuticals Inc.	P1	CC (44)
Brintellix Major Depressive Disorder	Seasons Biotechnology (Taizhou) Co., Ltd.	P1	CC (44)
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-Oh Major Depressive Disorder	University Hospital Tuebingen	P1/2	CC (44)
Sep-380135 Major Depressive Disorder	Otsuka Pharmaceutical Development & Commercialization, Inc.	P1	CC (44)
Valganciclovir Major Depressive Disorder	Laureate Institute for Brain Research, Inc.	P1/2	CC (44)
Dimethyltryptamine Major Depressive Disorder	Deepak C. D'Souza	P1	CC (43)
Plosaracetam Major Depressive Disorder	Syndesi Therapeutics	P1	CC (43)
sm-001 Major Depressive Disorder	Advanced Integrative Medical Science Institute	P1	CC (43)
Ele-101 Major Depressive Disorder	Eleusis Therapeutics	P1/2	CC (41)
Fosigotifator Major Depressive Disorder	AbbVie	P1	CC (41)
Clopidogrel Major Depressive Disorder	Assistance Publique - Hôpitaux de Paris	P1	CC (40)
Enx-104 Major Depressive Disorder	Engrail Therapeutics INC	P1	CC (40)
Baclofen Major Depressive Disorder	Mclean Hospital	Early P1	C (39)
Fluoroethylnormemantine Major Depressive Disorder	ReST Therapeutics	P1	C (37)
ly03021 Major Depressive Disorder	Luye Pharma Group Ltd.	P1	C (37)
Adderall-Xr Major Depressive Disorder	University of California, Los Angeles	Early P1	C (34)
Nitrogen Major Depressive Disorder	Massachusetts General Hospital	Early P1	C (34)
XENON Major Depressive Disorder	Massachusetts General Hospital	Early P1	C (34)
AIR Major Depressive Disorder	University Hospital, Tours	N/A	D (30)
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)- Major Depressive Disorder	Imperial College Healthcare NHS Trust	N/A	D (30)
Carbidopa Major Depressive Disorder	Charite University, Berlin, Germany	N/A	D (30)
Choline Alphoscerate Major Depressive Disorder	Samsung Medical Center	N/A	D (30)
Emono Major Depressive Disorder	University Hospital, Tours	N/A	D (30)
Flumazenil Major Depressive Disorder	Anders Jørgensen	N/A	D (30)
Diluent Major Depressive Disorder	Centre for Addiction and Mental Health	N/A	D (28)
.Gamma.-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-Octakis-S-(2-Carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-Octathio- Major Depressive Disorder	Medipol University	N/A	D (28)
Mitotempol Major Depressive Disorder	University of Delaware	N/A	D (28)
Ng-Nitro-L-Arginine Methyl Ester Major Depressive Disorder	University of Delaware	N/A	D (28)
Jieyu Chufan Capsules Major Depressive Disorder	Central South University	P4	NR ()
kh607 tablets Major Depressive Disorder	Chengdu Kanghong Pharmaceutical Group Co., Ltd.	P2	NR ()
sp-101 Major Depressive Disorder	Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.	P1	NR ()
Tnx-102 Sl Major Depressive Disorder	Tonix Pharmaceuticals, Inc.	P2	NR ()

Showing 151 to 198 of 198 assets

PreviousPage 4 of 4Next